Zimmer Biomet (NYSE:ZBH) is shaking up leadership in its Americas and Global Business Group organizations as the orthopedic device giant prepares to launch a next-gen ortho robot next year. The changes include former Nevro CEO Kevin Thornal leaving Zimmer Biomet on Sept. 30. Thornal joined ZB last year as group president, global businesses and the […]
Wall Street Beat
Medtronic veteran joins Teleflex’s board
Teleflex (NYSE: TFX) announced today that it has appointed Sean Salmon to its board of directors. Salmon previously spent more than two decades at Medtronic before stepping down in September of 2025. He most recently served as EVP and president of the medtech giant’s Cardiovascular portfolio. Before that, he led both Cardiovascular and Diabetes as […]
Boston Scientific could miss guidance over cybersecurity incident
Boston Scientific (NYSE: BSX) shares are down more than 5% today after the minimally invasive medtech company said a cybersecurity incident will make it unlikely to meet previously set full-year guidance. On July 29, the company reduced its full-year sales growth outlook to 5.5%–6.5% from the previous 7%–8.5% range. (A few months before, the company […]
MiniMed wins CE mark for next-gen insulin pump, ups revenue guidance
MiniMed (Nasdaq: MMED) today reported Street-beating first-quarter revenue, upping its full-year sales guidance as it notched an early European regulatory win. The Northridge, California–based diabetes tech company, spun out of Medtronic earlier this year, announced a CE mark for its next-gen, app-controlled MiniMed Flex insulin pump — well ahead of the company’s calendar 2026 year-end target. […]
Medtronic invests $780M in two companies amid Street-beating Q2
Medtronic (NYSE: MDT) blew past Wall Street’s high expectations amid double-digit revenue growth, driven by strong demand for AFib-treating pulsed-field ablation (PFA) and more. “Q1 represents a strong start to fiscal ’27. … These results reinforce our confidence in the durability of our growth,” CEO Geoff Martha said during the Minnesota-run medtech giant’s earnings call […]
The top 5 Medtronic stories of 2026 — so far
As a much-awaited Q1 earnings report approaches, here are the top stories of what has so far been a mostly positive year for Minnesota-run Medtronic (NYSE: MDT) — the world’s largest medtech company: 5. Calling for ‘deescalation’ after federal agents kill nurse Medtronic CEO Geoff Martha was among dozens of Minnesota business leaders calling for […]
Can Medtronic continue its rebound? We’ll get more answers soon
With less than a week until Medtronic (NYSE: MDT) announces its first-quarter earnings, the world’s largest medtech company has been riding rising stock and analyst upgrades. Though still not at the heights of up to $131 per share that they saw in 2021, MDT shares have been up more than 23%, to more than $92 […]
Royal Philips prices €650 million EU Green Bond
Royal Philips (NYSE: PHG) recently priced €650 million in fixed-rate notes due 2034 under its European Medium Term Note (EMTN) program. According to the company, these are “the healthcare industry’s first EU Green Bond under the new European Green Bond Standard.” The notes are priced at 99.655% of face value with a 4.0% coupon, giving […]
CVRx has an activist investor urging it to get acquired
A Michigan-based activist investor is urging CVRx (NASDAQ: CVRx) — the maker of the heart-failure-symptom-treating implantable Barostim system — to sell to a strategic acquirer. In a publicly released letter dated yesterday, Pointillist Family Office founder Jorey Chernett told CVRx’s board: “In the hands of a large medical device company with an established heart failure […]
Smith+Nephew CFO joins Baxter
Smith+Nephew (LON: SN, NYSE: SNN) CFO John Rogers plans to step down from his post at the British ortho and sports medicine tech giant to become EVP and CFO at Baxter in October. “I am honored to join Baxter, a company with a nearly century-long history, a powerful mission to save and sustain lives and an […]
Haemonetics reconnects with CSL in US plasma collection deal
Haemonetics (NYSE: HAE) is reconnecting with CSL Plasma, with a new deal to supply the donation collection provider with its latest hardware. In a filing yesterday with the SEC, Haemonetics said it expects CSL to begin transitioning some of its U.S. plasma collection centers to the company’s NexSys PCS platforms and disposable apheresis kits, following […]
